Answers are grounded in this paper and cite their sources.
We identified four ASM adherence trajectories in individuals with newly treated epilepsy. Whereas risk factors for early nonadherence such as race or geographic region are nonmodifiable, our work highlighted a modifiable risk factor for early nonadherence: lacking a neurologist. These data may guide future interventions aimed at improving ASM adherence, in terms of both timing and target populations.
No takes yet. Share an insight, caveat, or question.
Terman et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: